Wedbush Securities Inc. Sells 4,425 Shares of Oracle Corporation $ORCL

Wedbush Securities Inc. trimmed its position in Oracle Corporation (NYSE:ORCL) by 7.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 52,669 shares of the enterprise software provider’s stock after selling 4,425 shares during the period. Oracle comprises 0.5% of Wedbush Securities Inc.’s portfolio, making the stock its 27th biggest holding. Wedbush Securities Inc.’s holdings in Oracle were worth $14,813,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Kampmann Melissa S. increased its holdings in Oracle by 0.3% during the third quarter. Kampmann Melissa S. now owns 11,910 shares of the enterprise software provider’s stock valued at $3,350,000 after buying an additional 35 shares during the last quarter. McLean Asset Management Corp boosted its stake in shares of Oracle by 0.7% during the 3rd quarter. McLean Asset Management Corp now owns 5,319 shares of the enterprise software provider’s stock worth $1,551,000 after acquiring an additional 36 shares during the last quarter. Mine & Arao Wealth Creation & Management LLC. boosted its stake in shares of Oracle by 0.7% during the 3rd quarter. Mine & Arao Wealth Creation & Management LLC. now owns 5,281 shares of the enterprise software provider’s stock worth $1,485,000 after acquiring an additional 36 shares during the last quarter. Voisard Asset Management Group Inc. grew its position in shares of Oracle by 3.4% during the 3rd quarter. Voisard Asset Management Group Inc. now owns 1,127 shares of the enterprise software provider’s stock valued at $317,000 after acquiring an additional 37 shares during the period. Finally, Avion Wealth increased its stake in shares of Oracle by 16.6% in the 3rd quarter. Avion Wealth now owns 260 shares of the enterprise software provider’s stock worth $73,000 after purchasing an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Price Performance

ORCL stock opened at $157.18 on Thursday. The company has a debt-to-equity ratio of 3.28, a quick ratio of 0.91 and a current ratio of 0.91. The company’s fifty day moving average price is $186.04 and its 200-day moving average price is $232.32. Oracle Corporation has a one year low of $118.86 and a one year high of $345.72. The company has a market capitalization of $451.61 billion, a PE ratio of 29.55, a price-to-earnings-growth ratio of 1.40 and a beta of 1.64.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 EPS for the quarter, topping the consensus estimate of $1.64 by $0.62. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The business had revenue of $16.06 billion for the quarter, compared to analysts’ expectations of $16.19 billion. During the same quarter in the previous year, the company earned $1.47 EPS. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. On average, equities analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 23rd. Investors of record on Friday, January 9th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, January 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.3%. Oracle’s dividend payout ratio is presently 37.59%.

Insider Transactions at Oracle

In related news, CEO Clayton M. Magouyrk sold 10,000 shares of the firm’s stock in a transaction on Monday, February 9th. The shares were sold at an average price of $155.23, for a total value of $1,552,300.00. Following the completion of the transaction, the chief executive officer directly owned 134,030 shares of the company’s stock, valued at approximately $20,805,476.90. This trade represents a 6.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,223 shares of the business’s stock in a transaction on Tuesday, December 23rd. The stock was sold at an average price of $196.61, for a total transaction of $437,064.03. Following the completion of the sale, the director owned 25,596 shares in the company, valued at $5,032,429.56. This represents a 7.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 72,223 shares of company stock worth $13,689,064. 40.90% of the stock is owned by corporate insiders.

Oracle News Summary

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: CMS selected Oracle Cloud Infrastructure (OCI) to support its modernization initiative — a material, mission‑critical federal win that can generate multi‑year, sticky cloud revenue and strengthen OCI’s credibility with other large public‑sector customers. Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid’s Modernization Initiative
• Positive Sentiment: Product & commercial traction in healthcare — Oracle Health’s Clinical AI Agent (now available in the U.K.) and new customer wins (e.g., Hillsboro Health) demonstrate adoption of AI documentation and EHR migrations that can boost SaaS/cloud revenue and RPO. Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care
• Positive Sentiment: AI product momentum — Oracle rolled out AI agents for Fusion Apps and other Fusion enhancements (no‑cost deployment claims), reinforcing the company’s SaaS/cloud growth narrative. Oracle Unveils AI Agents for Fusion Apps
• Neutral Sentiment: OpenAI/AI linkage remains a sentiment driver — renewed optimism about Oracle’s exposure to OpenAI and AI infrastructure can lift sentiment but is speculative and dependent on partner outcomes. Oracle gets fresh boost from optimism around OpenAI exposure
• Neutral Sentiment: Short‑squeeze/volatility chatter: sector headlines (Barron’s, others) and elevated short interest mean ORCL can see amplified moves both higher (short‑covering) and lower (continued selling). Software Stocks Look Primed for a Short Squeeze
• Negative Sentiment: Legal overhang: multiple securities‑class action filings covering June–December 2025 introduce litigation risk and uncertainty that can pressure the stock and increase potential liabilities. Oracle Sued for Securities Law Violations
• Negative Sentiment: Insider selling: CEO Clayton Magouyrk sold 10,000 shares (~$1.55M). Single insider sales can be benign, but markets often view CEO sales as a negative signal if timed near other headwinds. SEC Form 4 — Clayton M. Magouyrk sale
• Negative Sentiment: Analyst revisions & guidance risk: Scotiabank trimmed FY2027 EPS forecasts (from $6.48 to $6.28), and some firms have downgraded or lowered targets amid scrutiny over AI monetization and Oracle’s leverage — these cuts can cap near‑term upside.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Weiss Ratings lowered Oracle from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, January 23rd. TD Cowen lowered their price objective on Oracle from $400.00 to $350.00 and set a “buy” rating on the stock in a research report on Thursday, December 11th. William Blair reiterated an “outperform” rating on shares of Oracle in a research note on Friday, October 17th. Erste Group Bank cut shares of Oracle from a “buy” rating to a “hold” rating in a research note on Monday, November 10th. Finally, Evercore lifted their price target on shares of Oracle from $350.00 to $385.00 and gave the company an “outperform” rating in a report on Friday, October 17th. Three research analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Oracle presently has an average rating of “Moderate Buy” and an average price target of $292.43.

About Oracle

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.